SCHRODER INVESTMENT MANAGEMENT GROUP - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$742,000
-94.6%
104,789
-93.2%
0.00%
-94.4%
Q4 2021$13,777,000
+2470.3%
1,541,106
+9984.5%
0.02%
+1700.0%
Q3 2021$536,000
+63.4%
15,2820.0%0.00%
Q2 2021$328,000
-80.6%
15,282
-44.1%
0.00%
-100.0%
Q1 2021$1,687,00027,3250.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$4,712,40033.11%
BML Capital Management, LLC 2,236,239$8,363,5347.52%
TANG CAPITAL MANAGEMENT LLC 3,026,455$11,318,9421.67%
Stonepine Capital Management, LLC 752,088$2,812,8091.02%
Bain Capital Life Sciences Investors, LLC 2,485,638$9,296,2860.96%
CM Management, LLC 250,000$9350.91%
EcoR1 Capital, LLC 6,995,861$26,164,5200.64%
Cormorant Asset Management, LP 1,547,181$5,786,4570.32%
SECTORAL ASSET MANAGEMENT INC 501,537$1,875,7480.31%
Auour Investments LLC 177,000$661,9800.28%
View complete list of ATEA PHARMACEUTICALS INC shareholders